Ortho Clinical Diagnostics Holdings plc
DelistedCIK 1828443fmd_0JM83EM0D65H7M311BCRKRX3AWManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard
Coverage: Dec 31, 2018 to Apr 03, 2022, 10 periods
| Line item | FY2019 | FY2020 | FY2021 |
|---|---|---|---|
| Total revenues | 1,802 | 1,766 | 2,043 |
| Cost of revenue | 922 | 908 | 1,007 |
| Gross profit | 879 | 858 | 1,036 |
| Research and development | 98 | 113 | 126 |
| Selling, general and administrative | 515 | 490 | 555 |
| Operating income | 86 | 88 | 174 |
| Interest expense | 231 | 198 | 146 |
| Other non-operating income (expense) | (6) | (84) | (53) |
| Income before taxes | (181) | (225) | (26) |
| Income tax expense | (24) | (13) | 28 |
| Net income from continuing operations | (157) | (212) | (54) |
| Net income | (157) | (212) | (54) |